Evidence map›Paper›PMID 27830154›Full record

ArticleBioMed research international2016

NRAMP1 Polymorphisms like Susceptibility Marker in Mexican Focus of Cutaneous Leishmaniasis.

Mirsha Pamela Hernández-Rivera, Alicia Ramírez-Ramírez, Adelaido Chiñas-Pérez, Amalia Monroy-Ostria, Mario Eugenio Cancino-Díaz, Omar Hernández-Montes

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Is the Prevalence ofAnimals : an open access journal from MDPI · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mirsha Pamela Hernández-RiveraDepartamento de Inmunología, Escuela Nacional de Ciencias Biológicas, IPN, Carpio y Plan de Ayala, 11340 Mexico City, Mexico.
Alicia Ramírez-RamírezDepartamento de Infectología e Inmunología, Instituto Nacional de Perinatología, Montes Urales 800, 11000 Mexico City, Mexico.
Adelaido Chiñas-PérezH. Ayuntamiento de Calakmul, Halaltun, 24640 Xpujil, CAM, Mexico.
Amalia Monroy-OstriaDepartamento de Inmunología, Escuela Nacional de Ciencias Biológicas, IPN, Carpio y Plan de Ayala, 11340 Mexico City, Mexico.ORCID 0000-0001-9942-2737
Mario Eugenio Cancino-DíazDepartamento de Inmunología, Escuela Nacional de Ciencias Biológicas, IPN, Carpio y Plan de Ayala, 11340 Mexico City, Mexico.
Omar Hernández-MontesDepartamento de Inmunología, Escuela Nacional de Ciencias Biológicas, IPN, Carpio y Plan de Ayala, 11340 Mexico City, Mexico.ORCID 0000-0001-7455-0070
Instituto Politécnico Nacional · MXInstituto Nacional de Perinatología · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous leishmaniasis (CL) is endemic in Campeche state, Mexico. Host and parasite factors are involved in the establishment and development of CL. Host factors include immune response and genetic background. NRAMP1 (Natural Resistance Associated Macrophage Protein 1) is important in innate immunity. Polymorphisms in

Indexed as

AdolescentAdultAgedAged, 80 and overCation Transport ProteinsChildFemaleGenetic MarkersGenetic Predisposition to DiseaseHumansLeishmaniasis, CutaneousMaleMexicoMiddle AgedNatural Resistance-associated Macrophage Protein 1Polymorphism, Single NucleotideCation Transport ProteinsGenetic MarkersNatural Resistance-associated Macrophage Protein 1

Identifiers

PMID27830154
PMCPMC5088330
OpenAlexW2534935608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.